search icon
search icon
Flag Arrow Down
Română
Română
Magyar
Magyar
English
English
Français
Français
Deutsch
Deutsch
Italiano
Italiano
Español
Español
Русский
Русский
日本語
日本語
中国人
中国人

Change Language

arrow down
  • Română
    Română
  • Magyar
    Magyar
  • English
    English
  • Français
    Français
  • Deutsch
    Deutsch
  • Italiano
    Italiano
  • Español
    Español
  • Русский
    Русский
  • 日本語
    日本語
  • 中国人
    中国人
Sections
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
About Us
Contact
Privacy policy
Terms and conditions
Quickly scroll through news digests and see how they are covered in different publications!
  • News
  • Exclusive
    • INSCOP Surveys
    • Podcast
    • EU
    • Diaspora
    • Republic of Moldova
    • Politics
    • Economy
    • Current Affairs
    • International
    • Sport
    • Health
    • Education
    • IT&C knowledge
    • Arts & Lifestyle
    • Opinions
    • Elections 2025
    • Environment
129 new news items in the last 24 hours
  1. Home
  2. Health

A global clinical study is testing a preventive vaccine for lung cancer, targeting individuals at high risk, with the aim of identifying and early eliminating abnormal cells.

Radu Burcă
whatsapp
facebook
linkedin
x
copy-link copy-link
27 November 2025, 16:38
main event image
Health
Foto: pexels.com
google-preference

Always see our news on Google

Lung cancer remains a lethal form of cancer, and its prevention is essential. A clinical study, launched by University College London and the University of Oxford, is testing an experimental vaccine called LungVax, aimed at individuals at high risk of lung cancer. Its goal is to induce an immune response that recognizes and eliminates lung cells with tumor changes before the disease manifests. The study, funded with over 2.3 million euros, will assess the safety and optimal dose of the vaccine, with a planned launch for the summer of 2026.

The vaccine is based on the identification of neoantigens, abnormal proteins expressed by cancer cells, which can be recognized by the immune system. In the first phase, the vaccine will be tested on individuals with early-stage lung cancer and on participants from the national screening program. If the results are favorable, the study will be expanded to assess the utility of the vaccine as a large-scale preventive strategy. In the United Kingdom, approximately 48,500 cases of lung cancer are reported annually, most of which are associated with smoking. The vaccine could complement existing preventive measures, providing a new approach in the fight against this devastating disease.

Sources

sursa imagine
News.ro
Primul vaccin experimental pentru prevenirea cancerului pulmonar, testat în premieră mondială
sursa imagine
Spotmedia
S-a descoperit un potențial factor declanșator al cancerului pulmonar. Boala poate fi prevenită!

Latest News

23:48

Prince Harry says he would enlist in the British Army again and warns that Europe must be prepared in the face of Russia

23:16

A Romanian man without a license stole a car and fled from police in Spain / The chase ended in a head-on collision

22:50

Hakeem Jeffries will lead the U.S. House of Representatives, becoming the first Black politician to hold the position

22:21

Eugen Tomac calls for reforming public administration and says that the option of eight regions can be analyzed

22:02

Traian Băsescu says Marian Neacșu will be the “executive prime minister” of the Luca Niculescu Government

See more news

NEWS ON THE SAME TOPICS

event image
Health
Moderna and Merck announce promising results for the personalized vaccine against melanoma recurrence
event image
Health
Alzheimer’s drug tested on people without symptoms. Researchers want to find out whether the disease can be prevented
event image
International
Russia will use the CaTeVac vaccine from 2027 to treat sarcomas
event image
International
WCRF warns: Seven types of cancer have become more common in people under 50
event image
Health
Târgu Jiu County Hospital offers free HPV testing to women between 18 and 65 years old, from November 11 to December 28
event image
EU
Commission proposes regular cardiovascular checks in all EU countries, from blood pressure to cholesterol and blood sugar
app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview app preview
study clinical trials lung cancer london cancer cells

Editor’s Recommendations

main event image
Exclusive
Yesterday 08:42

Exclusive Monitor of Ministers by NewsVibe: November 12–18, 2026 / Rogobete, Nazare and Neacșu top online visibility amid the Lyrica controversy and state-owned company reform

main event image
Exclusive
Yesterday 14:46

DOC Anthropic debuts Thursday on Nasdaq: the biggest test of the market’s enthusiasm for artificial intelligence

main event image
Current Affairs
Yesterday 09:57

SUMMARY Earthquake alerts: why Japan warns the population before the arrival of strong seismic waves, while Romania does not use RO-Alert

main event image
Exclusive
Yesterday 14:25

EXCLUSIVE Ranking of countries in relevant Romanian online sources: Ukraine leads the foreign agenda. Security and the economy define the week

main event image
Opinions
Yesterday 11:07

Raed Arafat, a Mr. Bean at DSU

app preview
Personalized news feed, AI-powered search, and notifications in a more interactive experience.
app preview
app store badge google play badge
  • News
  • Exclusive
  • INSCOP Surveys
  • Podcast
  • EU
  • Diaspora
  • Republic of Moldova
  • Politics
  • Economy
  • Current Affairs
  • International
  • Sport
  • Health
  • Education
  • IT&C knowledge
  • Arts & Lifestyle
  • Opinions
  • Elections 2025
  • Environment
  • About Us
  • Contact
Privacy policy
Cookies Policy
Terms and conditions
Open source licenses
All rights reserved Strategic Media Team SRL

Technology in partnership with

anpc-sal anpc-sol